ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1250 participants.
Also called NCT07453407
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,250 participants
- Registry
-
NCT07453407
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07453407. Randomized; single masking; primary purpose treatment. Start 2026-03-05 (actual); primary completion 2029-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
- Acronym
- ART
- Condition
- Aortic Regurgitation
- Condition
- Aortic Valve Insufficiency
- Condition
- Aortic Insufficiency
- Intervention (Device)
- J-VALVE Transfemoral Aortic Valve system
- Intervention (Device)
- Commercially available surgical biological aortic valve replacement device
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct07453407- Content hash
b193a2fb5bb577f4d09a1b6c245202a4169b4355db31028d1d6e810e74e570a8